Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
BiOptix is pleased to announce the appointment of Dr. Scott Klakamp as Vice President of Chemistry and Biochemistry. Scott joins the company after...
BiOptix is pleased to announce the appointment of Ken Dickerson as Vice President of Sales. Ken joins the company from ACEA Biosciences where he was...
BiOptix, exhibiting this week at the Antibody Engineering & Therapeutics Summit, will sponsor a scientific briefing entitled: "Slow Off-Rate Modified ...
BiOptix, while participating in the 12th Annual Discovery on Target Symposia, formally announced its fall 2014 scientific symposia and event schedule....
BiOptix announced today an additional $1.4M financing from existing investors. The funds will be used to expand sales and marketing and ramp up...
BiOptix, in conjunction with Altermune Technologies announced today the presentation of a poster for "Quantitative SPR Screening of Aptamer-Protein...
BiOptix is pleased to announce its participation in the 9th annual Next Generation Protein Therapeutics Summit, being held in conjunction with the...
With its participation in the 58th annual Biophysical Society Meeting from February 15 – 19, along with the 21st International Molecular Medicine...
BiOptix continues support of the global antibody engineering and therapeutics research community through participation in IBC's 24th Annual Antibody...
BiOptix formally announced the European expansion of the BiOptix Innovators Program at MipTec & BioValley Life Sciences Week, being held in Basel,...
BiOptix formally announces a unique to the industry research collaboration with the Biophysics Shared Resource Core Facility at the University of...
BiOptix today announced participation and support in IBC's 8th Annual Next Generation Protein Therapeutics Summit in San Diego, California. At the...
BiOptix will present new and compelling PSA (Prostate-Specific Antigen) data from the BiOptix 404pi, the first commercially available SPR instrument...
BiOptix announced today that it will be showcasing the new BiOptix 404pi at IBC's 23rd Annual Antibody Engineering and Therapeutics Conference in San ...
BiOptix today announced that it would be highlighting the new BiOptix 404pi, the first commercially available SPR instrument to incorporate...
BiOptix today announced the BiOptix Innovators Program, a pioneering instrument trial program that encourages researchers and institutions to become...
BiOptix officially announced that it has expanded sales and marketing efforts outside of the United States and into Europe with participation in...
BiOptix announced continued support of the Colorado BioScience Association today, with participation in BioWest 2012, a leading life sciences...
BiOptix today officially announced its fall 2012 Tradeshow and Symposia schedule. These events will highlight the BiOptix Enhanced Surface Plasmon...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.